These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 18729476)

  • 1. Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches.
    Bobst CE; Abzalimov RR; Houde D; Kloczewiak M; Mhatre R; Berkowitz SA; Kaltashov IA
    Anal Chem; 2008 Oct; 80(19):7473-81. PubMed ID: 18729476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional differences between glycosylated and non-glycosylated forms of human interferon-beta (IFN-beta).
    Runkel L; Meier W; Pepinsky RB; Karpusas M; Whitty A; Kimball K; Brickelmaier M; Muldowney C; Jones W; Goelz SE
    Pharm Res; 1998 Apr; 15(4):641-9. PubMed ID: 9587963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of intact protein conjugates and biopharmaceuticals using ion-exchange chromatography with online detection by native electrospray ionization mass spectrometry and top-down tandem mass spectrometry.
    Muneeruddin K; Nazzaro M; Kaltashov IA
    Anal Chem; 2015 Oct; 87(19):10138-45. PubMed ID: 26360183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro biological characterization of IFN-β-1a major glycoforms.
    Mastrangeli R; Rossi M; Mascia M; Palinsky W; Datola A; Terlizzese M; Bierau H
    Glycobiology; 2015 Jan; 25(1):21-9. PubMed ID: 25117008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation and dynamics of biopharmaceuticals: transition of mass spectrometry-based tools from academe to industry.
    Kaltashov IA; Bobst CE; Abzalimov RR; Berkowitz SA; Houde D
    J Am Soc Mass Spectrom; 2010 Mar; 21(3):323-37. PubMed ID: 19963397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deciphering the Biophysical Effects of Oxidizing Sulfur-Containing Amino Acids in Interferon-beta-1a using MS and HDX-MS.
    Houde DJ; Bou-Assaf GM; Berkowitz SA
    J Am Soc Mass Spectrom; 2017 May; 28(5):840-849. PubMed ID: 28194741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry-based methods to study protein architecture and dynamics.
    Kaltashov IA; Bobst CE; Abzalimov RR
    Protein Sci; 2013 May; 22(5):530-44. PubMed ID: 23436701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsed-alkylation mass spectrometry for the study of protein folding and dynamics: development and application to the study of a folding/unfolding intermediate of bacterial luciferase.
    Apuy JL; Park ZY; Swartz PD; Dangott LJ; Russell DH; Baldwin TO
    Biochemistry; 2001 Dec; 40(50):15153-63. PubMed ID: 11735398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced mass spectrometry-based methods for the analysis of conformational integrity of biopharmaceutical products.
    Bobst CE; Kaltashov IA
    Curr Pharm Biotechnol; 2011 Oct; 12(10):1517-29. PubMed ID: 21542797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of an interferon-beta1a product.
    Kauffman MA; Sterin-Prync A; Papouchado M; González E; Vidal AJ; Grossberg SE; Chuppa S; Odoriz B; Vrech C; Diez RA; Ferro HH
    Int J Immunopathol Pharmacol; 2011; 24(2):499-504. PubMed ID: 21658324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometric approaches using electrospray ionization charge states and hydrogen-deuterium exchange for determining protein structures and their conformational changes.
    Yan X; Watson J; Ho PS; Deinzer ML
    Mol Cell Proteomics; 2004 Jan; 3(1):10-23. PubMed ID: 14623985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encephalomyocarditis Virus Abrogates the Interferon Beta Signaling Pathway via Its Structural Protein VP2.
    Han Y; Xie J; Xu S; Bi Y; Li X; Zhang H; Idris A; Bai J; Feng R
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33328314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.
    Pepinsky RB; LePage DJ; Gill A; Chakraborty A; Vaidyanathan S; Green M; Baker DP; Whalley E; Hochman PS; Martin P
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1059-66. PubMed ID: 11356929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Getting to the core of protein pharmaceuticals--Comprehensive structure analysis by mass spectrometry.
    Leurs U; Mistarz UH; Rand KD
    Eur J Pharm Biopharm; 2015 Jun; 93():95-109. PubMed ID: 25791210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformational heterogeneity of stability of apomyoglobin studied by hydrogen/deuterium exchange and electrospray ionization mass spectrometry.
    Wang F; Tang X
    Biochemistry; 1996 Apr; 35(13):4069-78. PubMed ID: 8672441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Top-down mass spectrometry and hydrogen/deuterium exchange for comprehensive structural characterization of interferons: implications for biosimilars.
    Pan J; Borchers CH
    Proteomics; 2014 May; 14(10):1249-58. PubMed ID: 24574185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural analysis of modified forms of recombinant IFN-beta produced under stress-simulating conditions.
    Orrù S; Amoresano A; Siciliano R; Napoleoni R; Finocchiaro O; Datola A; De Luca E; Sirna A; Pucci P
    Biol Chem; 2000 Jan; 381(1):7-17. PubMed ID: 10722045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring the hydrogen/deuterium exchange of proteins at high spatial resolution by mass spectrometry: overcoming gas-phase hydrogen/deuterium scrambling.
    Rand KD; Zehl M; Jørgensen TJ
    Acc Chem Res; 2014 Oct; 47(10):3018-27. PubMed ID: 25171396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyalkylated histidine is a pH-dependent product of pegylation with SC-PEG.
    Wylie DC; Voloch M; Lee S; Liu YH; Cannon-Carlson S; Cutler C; Pramanik B
    Pharm Res; 2001 Sep; 18(9):1354-60. PubMed ID: 11683252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.